Takeda Pharmaceutical Co Ltd
SWB:TKDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takeda Pharmaceutical Co Ltd
SWB:TKDA
|
JP |
|
Schlumberger NV
NYSE:SLB
|
US |
|
C
|
China Reinsurance Group Corp
F:C53
|
CN |
|
A
|
Abeona Therapeutics Inc
F:PCJP
|
US |
|
Takashimaya Co Ltd
TSE:8233
|
JP |
|
Lindbergh SpA
F:D8M
|
IT |
|
Kraft Heinz Co
NASDAQ:KHC
|
US |
|
Star Mica Holdings Co Ltd
TSE:2975
|
JP |
|
Sequans Communications SA
NYSE:SQNS
|
FR |
Wall St Price Targets
TKDA Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TKDA is 17.47 EUR with a low forecast of 14.39 EUR and a high forecast of 22.73 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKDA's stock price target?
Price Target
17.47
EUR
According to Wall Street analysts, the average 1-year price target for TKDA is 17.47 EUR with a low forecast of 14.39 EUR and a high forecast of 22.73 EUR.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is -5%.
What is the Net Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
44%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 44%.
